ICS OPPORTUNITIES II LLC 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-12 4:21 pm Purchase |
2024-09-09 | 13G | Aligos Therapeutics, Inc. ALGS |
ICS OPPORTUNITIES II LLC | 125,451 4.100% |
125,451 (New Position) |
Filing |